Department of Surgery, Campus Charité-Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Clinical Scientist Program, Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.
Langenbecks Arch Surg. 2023 Aug 7;408(1):296. doi: 10.1007/s00423-023-03023-y.
The present study assesses long-term overall survival (OS) and disease-free survival (DFS) after curative resection for intrahepatic cholangiocarcinoma (ICCA) depending on resection margin (RM) status and lymph node (LN) status.
Clinical data of all consecutively resected patients with ICCA at a single high-volume center between 2005 and 2018 were collected. Minimum follow-up was 36 months. Perioperative and long-term oncological outcome was assessed.
One hundred ninety-two cases were included in the analysis. Thirty- and 90-day-mortality was 5.2% (n = 10) and 10.9% (n = 21). OS was 26 months with 1-, 2-, and 5-year-OS rates of 72%, 53%, and 26%. One-, 2-, and 5-year-DFS rates were 54%, 42%, and 35% (N0 vs. N1: 29 vs. 9 months, p = 0.116). R1 was not found to be an independent risk factor for reduced survival in the overall cohort (p = 0.098). When differentiating according to the LN status, clear resection margins were significantly associated with increased DFS for N0 cases (50 months vs. 9 months, p = 0.004). For N1 cases, no significant difference in DFS was calculated for R0 compared to R1 cases (9 months vs. 9 months, p = 0.88). For N0 cases, clear resection margins > 10 mm were associated with prolonged OS (p = 0.048).
For N1 cases, there was no significant survival benefit when comparing R0 versus R1, while the complication rate remained high for the extended resection types. In view of merging multimodal treatment, the hilar first concept assesses locoregional LN status for optimal surgical therapy.
本研究评估了根治性切除术后肝内胆管癌(ICCAs)的长期总生存(OS)和无病生存(DFS),依据的是切缘(RM)状态和淋巴结(LN)状态。
收集了 2005 年至 2018 年间在一家高容量中心连续接受 ICCA 根治性切除术的所有患者的临床资料。最低随访时间为 36 个月。评估围手术期和长期肿瘤学结果。
192 例患者纳入分析。30 天和 90 天死亡率分别为 5.2%(n=10)和 10.9%(n=21)。OS 为 26 个月,1 年、2 年和 5 年 OS 率分别为 72%、53%和 26%。1 年、2 年和 5 年 DFS 率分别为 54%、42%和 35%(N0 与 N1:29 个月与 9 个月,p=0.116)。R1 在总体队列中并不是生存时间缩短的独立危险因素(p=0.098)。当根据 LN 状态进行区分时,对于 N0 病例,清晰的切缘与 DFS 的增加显著相关(50 个月与 9 个月,p=0.004)。对于 N1 病例,R0 与 R1 病例之间的 DFS 无显著差异(9 个月与 9 个月,p=0.88)。对于 N0 病例,切缘>10mm 时,OS 延长(p=0.048)。
对于 N1 病例,R0 与 R1 相比,生存获益无显著差异,而扩大切除类型的并发症发生率仍然较高。鉴于合并多模态治疗,肝门部优先概念评估局部区域 LN 状态,以获得最佳手术治疗。